Back

MECP2-mutant marmosets exhibit primate-specific phenotypes of Rett syndrome

Kishi, N.; Okahara, J.; Sato, K.; Yoshimaru, D.; Kurotaki, Y.; Onishi, K.; Sanosaka, T.; Henry, R.; Ito, T.; Okuno, M.; Weinstein, E. J.; Crittenden, J. R.; Okano, H. J.; Hata, J.; Kohyama, J.; Sasaki, E.; Shimogori, T.; Okano, H.

2026-06-29 neuroscience
10.64898/2026.06.26.734672 bioRxiv
Show abstract

We used genome editing to generate MECP2-knockout marmosets and establish a new primate model for Rett syndrome (RTT), a neurodevelopmental disorder. MRI analysis of this marmoset model revealed diminished cortico-cortical connections, particularly those originating in the prefrontal cortex. Detailed histological analysis revealed reduced dendritic arborization and synaptic density, particularly in the upper layers of the cerebral cortex. Cortical layer II/III excitatory neurons appeared to be immature based on single-nucleus RNA sequencing and spatial transcriptomics, while PVALB-positive interneurons exhibited upregulation of neuronal maturation-related transcripts. Moreover, the neurodevelopmental disease gene GABAB receptor 2 (GABBR2) emerged as a conserved downstream target of MECP2, illuminating a cellular cascade that could be targeted in preclinical and therapeutic drug development. Many of the gene expression changes observed in the marmoset model are common in RTT patients, thereby highlighting molecular links from cell type-specific phenotypes in the marmoset model to the RTT clinical presentation.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.